FSSAI suspends licences of 6 nutraceutical firms over safety violations
Synopsis
Key Takeaways
The Food Safety and Standards Authority of India (FSSAI) on Monday, 16 November 2026, announced regulatory action against six nutraceutical manufacturers, including suspension of licences, following the detection of serious food safety and compliance violations during recent facility inspections. The crackdown signals an intensifying scrutiny of India's fast-growing nutraceutical sector — a category of food-derived products marketed for specific health benefits beyond basic nutrition.
Companies Facing Action
The six firms named by FSSAI are Airen Herbals, Aquabliss Lifesciences, Raskam Healthcare, Supercure Biotech, Ambico Ayurvedic Healthcare, and Vedant Remedies. Inspectors identified violations ranging from excess nutrient levels and mislabelling to the use of expired raw materials and the presence of pathogenic microbial strains.
Key Violations Found
At Airen Herbals, the product 'Lycowey Syrup' was found to contain thiamin, vitamin E acetate, copper, selenium, and zinc at levels exceeding prescribed Recommended Dietary Allowance (RDA) limits per serving. A second product, 'Maxford Pain Relief', was flagged for making unauthorised claims related to knee relief, using imagery associated with pain relief, and non-compliance in botanical ingredient declarations.
Aquabliss Lifesciences was cited for storing expired raw materials at its manufacturing site alongside poor sanitation and hygiene standards. Raskam Healthcare was found using Shilajit — an ingredient not approved for the identified products — along with deficiencies in record-keeping and documentation.
Inspections at Supercure Biotech revealed multiple irregularities: its 'Gemkolin 9G softgel capsules' contained biotin levels exceeding the maximum permitted limit; a product marketed as a vitamin E softgel capsule was found to contain wheat germ oil instead of vitamin E — a substitution authorities said could mislead consumers. The company was also flagged for labelling deficiencies and the presence of non-permitted and pathogenic microbial strains in its probiotic products.
Ambico Ayurvedic Healthcare was found using expired materials in nutraceutical preparations while maintaining inadequate hygiene standards at its manufacturing premises. Vedant Remedies was cited for the use of expired materials in flavouring products, sanitation shortcomings, housekeeping deficiencies, and inadequate manufacturing infrastructure and testing facilities.
Why This Matters
India's nutraceutical industry has expanded rapidly in recent years, riding post-pandemic demand for immunity and wellness products. However, the sector has long faced concerns about inconsistent regulation, with critics arguing that enforcement has lagged behind market growth. This is among the most comprehensive enforcement actions FSSAI has publicly disclosed against nutraceutical firms, covering a broad sweep of violations — from product formulation and labelling to hygiene and testing infrastructure. Consumers relying on these products for specific health outcomes face the risk of either ineffective formulations or, in some cases, potentially harmful ones.
What Happens Next
FSSAI has stated that it has intensified inspections of manufacturing facilities in recent months and will continue to identify instances of non-compliance. The affected companies are expected to face formal proceedings, and licence reinstatement would typically require demonstrated corrective action. Industry associations are likely to face pressure to adopt stronger self-regulatory frameworks in the wake of the action.